Showing results (41-50 of 350) with videos related to

Sort By:
Pageof 35
Gynecologic Oncology|February 27, 2013
HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survivalHelene Tuft Stavnes, Arild Holth, Trinh Don, et al.
Human Pathology|February 16, 2010
Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinomaMari Bunkholt Elstrand, Hiep Phuc Dong, Elin Ødegaard, et al.
American Journal of Clinical Pathology|April 15, 2006
NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinomaHiep Phuc Dong, Mari Bunkholt Elstrand, Arild Holth, et al.
Human Pathology|January 23, 2009
Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinomaLilach Kleinberg, Hiep Phuc Dong, Arild Holth, et al.
Virchows Archiv : an International Journal of Pathology|September 5, 2024
Endometrial carcinomas with ambiguous histology often harbor TP53 mutationsBen Davidson, Karin Teien Lande, Daniel Nebdal, et al.
American Journal of Clinical Pathology|October 23, 2009
Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parametersHiep Phuc Dong, Arild Holth, Lilach Kleinberg, et al.
Human Pathology|November 2, 2012
Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistanceThea Eline Hetland, Dag Andre Nymoen, Arild Holth, et al.
Human Pathology|December 3, 2014
The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusionsBen Davidson, Arild Holth, Ellen Hellesylt, et al.
Gynecologic Oncology|November 27, 2012
Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcomaBen Davidson, Vera Maria Abeler, Ellen Hellesylt, et al.
Human Pathology|April 12, 2016
MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinomaDag Andre Nymoen, Ana Slipicevic, Arild Holth, et al.
Pageof 35